The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

Dermatitis. 2010;21(1):59-60. A 47-year-old female presented for evaluation of a pruritic and painful vulvar dermatitis. The dermatitis began approximately 3 years prior to presentation, shortly ...

A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

World Patient Safety Day provides an occasion to spread awareness of the medication errors that can result from products that ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...

Despite the advances in breast imaging, there are clear indications for the need of clinical breast examination as part of breast cancer screening for all women. The article reviews the technique ...

The diagnosis of precore mutant chronic hepatitis B (CHB) can be made with safety only by sequencing the precore region of the hepatitis B virus (HBV) genome, a method not widely available.

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

APAP is the most common identifiable cause of ALF in children living in the United States and United Kingdom. [9] The PALF study has confirmed at least two clinical presentations; the first is an ...